Ovaphil-S
Ovaphil-S
We make things that work better and last longer. Our products solve real problems with clean design and honest materials.
- OBGYN RECOMMENDED
- INGREDIENT TRANSPARENCY
We have nothing to hide, and we proudly disclose every hand-selected ingredient.
Ovaphil-S is a fertility medication, Sildenafil Citrate 25 mg, that helps improve receptivity of the endometrium by increasing blood flow in the uterus. It is useful in the thin endometrium, implantation failure and repeat implantation failure IVF cycles. Improved endometrium thickness and vascularity help to provide a better environment for the embryo to implant and increase the likelihood of pregnancy.
A well-researched formulation of Sildenafil Citrate 25 mg, indicating the endometrial thickness and improvement in uterine blood flow, especially in women undergoing infertility treatment such as IUI, IVF, or other assisted reproductive techniques (ART) . This is prescribed when the receptivity of the thin endometrium or the bad uterus is suspected of being a barrier to implantation.
Sildenafil, a selective phosphodiesterase type -5 inhibitor (PDE5I), works by increasing nitric oxide (NO) -mediated vasodilation. This mechanism increases the blood flow of the uterus, which improves endometrial growth and reception – two important parameters for implantation of the fetus and successful pregnancy.
Mechanism of Action
- PDE5 prevents enzymes, prevents cyclic GMP (CGMP) breakdown
- Vascular smooth muscle enhances nitric oxide butterfly effects
- Promotes vasodilation in uterine arteries
- Increases blood perfusion for endometrial lining
- Endometrial proliferation and thickness improves
Embryo optimizes uterine environment for implantation
Clinical Use & Dosage
- Standard doses: Sildenafil Citrate 25 mg Tablet is taken 2-4 times daily, usually starts at 8 days of the menstrual cycle and continued until the day of ovulation or embryo transfer depending on the protocol.
- Route: Oral or vaginal administration depending on physician preference and patient response.
- Ultrasound monitoring of endometrial thickness is advised during therapy.
Indications
- Thin endometrium (<7 mm) in ovulation induction or ART cycles
- Frequent implantation failure due to poor endometrial development
- The intrauterine development retardation is associated with the uterine blood flow
Adjunct therapy to increase the medical reception of the frozen embryo transfer (FET) cycle
Key Benefits of Ovaphil S (Sildenafil Citrate 25 mg)
-
Proven Improvement in Endometrial Thickness
Some studies have shown that Sildenafil enhances endometrial growth in patients with inadequate thickness, often achieving a target lining of 7 mm, which is considered the best for embryo implantation. -
Increased Uterine Blood Flow
By vasodilating the uterine arteries, the ovafil S improves the endometrial perfusion, leading to an increase in the distribution of oxygen and nutrients, which promotes the more receptive endometrial environment. -
Enhanced Implantation Rates
Better uterine receptivity is directly correlated with high implantation and clinical pregnancy rates, especially in ART cycles such as IVF or ICSI. -
Safe and Well-Tolerated
The Sildenafil citrate has a favorable protection profile when used in gynecological practice. It is well tolerated with minimal side effects, including headaches, flushing, nasal congestion, or dizziness-mild and self-limiting. -
Beneficial in Recurrent Implantation Failure (RIF)
Ovaphil S may provide new hope to patients with frequent implantation failure where suboptimal endometrium is a suspicious contribution factor. It has become an important tool in personalized fetal transfer protocols. -
Oral & Vaginal Flexibility
formulation can be administered both oral and vaginally, direct local action along the vaginal passage and better efficacy in increasing the blood flow of the uterus without systemic side effects. -
Complementary to Fertility Protocols
Ovafil S can be united in various reproductive treatment schemes, including:
- Ovulation induction (OI) with letrozole or clomiphene
- Intrauterine insemination (IUI) cycles
- IVF/ICSI fresh and frozen embryo transfer cycles
- Luteal phase support in endometrial priming
Ovaphil S – Sildenafil Citrate 25 mg tablets offer a targeted, evidence-based solution for improving endometrial receptivity in women struggling with implantation challenges or thin endometrial lining.It increases the blood flow of the uterus and optimizes the endometrial environment, thus contributing to better clinical consequences in fertility treatment.
Note: Ovaphil S should be used under the supervision of a reproductive specialist or gynecologist. The dose and duration of the patient’s response and treatment protocol should be made individually.
To access comprehensive guidance on enhancing endometrial thickness and uterine blood flow for better fertility outcomes, see our full guide: Read Now...